1. Inflammatory Breast Cancer Survival: The Role of Obesity and Menopausal Status at Diagnosis

   • Shine Chang
   • Julie R. Alderfer
   • Aman U. Buzdar

   OriginalPaper Pages: 157 - 163

2. Preliminary Assessment of Cognitive Function in Breast Cancer Patients Treated with Tamoxifen

   • Annlia Paganini-Hill
   • Linda J. Clark

   OriginalPaper Pages: 165 - 176

3. Liarozole Fumarate (R85246): In the Treatment of ER Negative, Tamoxifen Refractory or Chemotherapy Resistant Postmenopausal Metastatic Breast Cancer

   • Paul E. Goss
   • Kathrin Strasser
   • Shangle Qi

   OriginalPaper Pages: 177 - 188

4. Polyadenylic–Polyuridylic Acid Plus Locoregional Radiotherapy Versus Chemotherapy with CMF in Operable Breast Cancer: a 14 Year Follow-up Analysis of a Randomized Trial of the Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC)

   • A. Laplanche
   • L. Alzieu
   • J. Lacour

   OriginalPaper Pages: 189 - 191

5. Selective Decrease of Serum Immunoglobulin G1 as Marker for Early Stages of Invasive Breast Cancer

   • L. Kronberger
   • W. Steinschifter
   • K. Schauenstein

   OriginalPaper Pages: 193 - 199

6. Alcohol and Breast Cancer Mortality in a Cohort Study

   • M.G. Jain
   • R.G. Ferrence
   • A.B. Miller

   OriginalPaper Pages: 201 - 209

7. Inhibition of NF-κB Activity Enhances TRAIL Mediated Apoptosis in Breast Cancer Cell Lines

   • Maccon M. Keane
   • Yaffa Rubinstein
   • Stan Lipkowitz

   OriginalPaper Pages: 211 - 219

8. PTP LAR Expression Compared to Prognostic Indices in Metastatic and Non-Metastatic Breast Cancer

   • Charles M. LeVea
   • Carl T. McGary
   • Robert A. Mooney

   OriginalPaper Pages: 221 - 228